| Literature DB >> 25369320 |
Lili Niu1, Yanling Zhang2, Long Meng1, Yang Xiao1, Kelvin K L Wong3, Derek Abbott3, Hairong Zheng1, Rongqin Zheng2, Ming Qian1.
Abstract
OBJECTIVE: Atherosclerosis is a chronic and systemic disease and its developmental process involves the synergism of multiple risk factors such as hypertension, dyslipidemia, diabetes, obesity and smoking. The diagnosis of subclinical atherosclerosis is essential for strategic guidance towards suitable treatments and efficient prevention against acute cardiovascular events. This study employed ultrasound radiofrequency (RF) tracking technology to characterize human carotid arteries in vivo in terms of intima-media thickness (IMT) and artery stiffness, and evaluated the statistical correlation between carotid IMT and stiffness, and the number of risk factors for atherosclerosis.Entities:
Mesh:
Year: 2014 PMID: 25369320 PMCID: PMC4219816 DOI: 10.1371/journal.pone.0111926
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of subjects with different numbers of risk factors.
| Characteristics | Zero ( | Single ( | Double ( | Multiple ( |
| Age (years) | 37.37±14.21 | 46.09±16.69 | 53.75±10.26 | 57.21±12.45 |
| Male gender (%) | 35%,17/48 | 41%,9/22 | 42%,22/52 | 61%,23/38 |
| SBP (mmHg) | 115.00±9.90 | 121.64±11.40 | 125.13±15.54 | 135.39±18.50 |
| DBP (mmHg) | 73.13±6.31 | 75.91±8.14 | 76.00±8.23 | 81.29±12.75 |
| PP (mmHg) | 41.88±8.97 | 45.73±9.12 | 49.13±12.28 | 54.11±13.92 |
| Height (cm) | 163.56±7.33 | 164.05±7.03 | 162.54±8.44 | 163.84±8.51 |
| Weight (kg) | 56.58±9.56 | 61.14±11.34 | 64.02±10.05 | 70.11±12.37 |
| BMI (kg/m2) | 21.04±2.44 | 22.63±3.26 | 24.12±2.36 | 26.05±3.69 |
| TC (mmol/L) | 4.24±0.76 | 5.24±1.83 | 5.02±1.01 | 4.84±0.93 |
| TG (mmol/L) | 1.02±0.35 | 2.36±3.07 | 1.83±1.40 | 2.91±3.04 |
| HDL-C (mmol/L) | 1.37±0. 33 | 1.26±0.32 | 1.12±0.23 | 1.06±0.28 |
| LDL-C (mmol/L) | 2.46±0.57 | 3.14±1.17 | 3.31±0.89 | 3.04±0.74 |
| FBG (mmol/L) | 5.00±0.54 | 7.23±5.72 | 9.18±6.17 | 9.88±4.46 |
| Hypertension (%) | 0,0/48 | 13.6%,3/22 | 38.5%,20/52 | 76.3%,29/38 |
| Dyslipidemia (%) | 0,0/48 | 54.5%, 12/22 | 76.9%,40/52 | 97.4%,37/38 |
| Diabetes (%) | 0,0/48 | 22.7%,5/22 | 69.2%,36/52 | 86.8%,33/38 |
| Obesity (%) | 0,0/48 | 0, 0/22 | 0, 0/52 | 15.8%,6/38 |
| Smoking (%) | 0,0/48 | 9%,2/22 | 17.3%,9/52 | 50.0%,19/38 |
| MAXIMT (mm) | 0.460±0.15 | 0.556±0.16 | 0.723±0.22 | 0.816±0.30 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; BMI, body mass index; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FBG, fasting blood glucose; MAXIMT, maximum intima-media thickness.
Figure 1The illustration for the ultrasound radiofrequency (RF)-tracking technology.
(a) The diagram for the RF-QIMT technology. A green box is chosen to define the region of interest (ROI). On the right it shows a typical RF signal that corresponds to the red rectangle in the ROI, with the RF raw signal denoted in blue, and the RF envelop denoted in red. The ‘Intima Peak’, ‘Media Foot’, and ‘Adventitia Peak’ are identified in the RF envelop in order to determine the interfaces between the intima, the media, and the adventitia in the artery. The green line inside the ROI denotes the intima and the orange line denotes the adventitia. The intima-media thickness (IMT) can therefore be obtained. (b) The diagram for the RF-QAS technology. In the same ROI, the diameter waveform is tracked as a function of time using a complex cross-correlation model, and the cardiac cycle is acquired based on the waveform periodicity. Combining with the brachial blood pressure information (systolic blood pressure and diastolic blood pressure), five arterial stiffness coefficients can be calculated, including distensibility coefficient (), compliance coefficient (), index, index and local pulse wave velocity ().
The Spearman’s rho Correlation Analysis between MAXIMT and RFQIMT, DC, CC, α, β, PWVβ measured by the ultrasound RF-tracking technology.
| RFQIMT (mm) | DC (1/kPa) | CC (mm2/kPa) | α index | β index | PWVβ (m/s) | ||
| All subjects ( | |||||||
| MAXIMT | Spearman’s rho | 0.792** | –0.503** | –0.338** | 0.531** | 0.537** | 0.538** |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| Subjects with MAXIMT<1.0 mm ( | |||||||
| MAXIMT | Spearman’s rho | 0.749** | –0.539** | –0.409** | 0.574** | 0.580** | 0.588** |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
DC, distensibility coefficient; CC, compliance coefficient. **p<0.01.
The ANCOVA of RFQIMT, DC, CC, α, β, PWVβ in two groups of non-atherosclerosis subjects (MAXIMT<1.0 mm).
| Parameters | Subjects without riskfactor ( | Subjects with risk factors ( | F value |
|
| RFQIMT (mm) | 0.560±0.019 | 0.608±0.012 | 4.079 | 0.045 |
| DC (1/kPa) | 0.024±0.002 | 0.017±0.001 | 7.524 | 0.007 |
| CC (mm2/kPa) | 0.900±0.055 | 0.755±0.036 | 4.403 | 0.038 |
| α index | 5.047±0.432 | 6.135±0.286 | 3.972 | 0.048 |
| β index | 10.235±0.861 | 12.447±0.570 | 4.131 | 0.044 |
| PWVβ (m/s) | 7.470±0.297 | 8.327±0.197 | 5.191 | 0.024 |
ANCOVA, the analysis of covariance; with age as covariate, age = 47.06.
The ANCOVA of RFQIMT, DC, CC, α, β, PWVβ in four groups of non-atherosclerosis subjects (MAXIMT<1.0 mm).
| Zero( | Single( | Double( | Multiple( | F value |
| |
| RFQIMT (mm) | 0.554±0.018 | 0.54±0.025 | 0.611±0.017 | 0.660±0.022 | 5.844 | 0.01 |
| DC (1/kPa) | 0.024±0.002 | 0.019±0.003 | 0.018±0.002 | 0.015±0.002 | 2.924 | 0.036 |
| CC (mm2/kPa) | 0.905±0.055 | 0.835±0.075 | 0.723±0.051 | 0.740±0.065 | 1.975 | 0.121 |
| α index | 4.952±0.428 | 4.952±0.583 | 6.389±0.402 | 6.714±0.508 | 3.238 | 0.024 |
| β index | 10.05±0.854 | 10.10±1.162 | 12.96±0.801 | 13.59±1.013 | 3.284 | 0.023 |
| PWVβ (m/s) | 7.399±0.294 | 7.489±0.4 | 8.425±0.276 | 8.872±0.348 | 4.057 | 0.008 |
ANCOVA, with age as covariate, age = 47.06.
p<0.05 Zero vs Double;
p<0.05 Zero vs Multiple;
p<0.05 Single vs Double;
*p<0.05 Single vs Double;
p<0.05 Single vs Multiple;
p<0.05 Double vs Multiple.
The stepwise multiple linear regression analysis of independent risk factors for the RFQIMT and carotid stiffness.
| Variables | Coefficient (β) | Standard Error | 95% CI |
|
|
| RFQIMT (mm) | |||||
| Constant | –0.022 | 0.090 | –0.199–0.155 | –0.246 | 0.806 |
| Age (years) | 0.504 | 0.001 | 0.005–0.008 | 7.395 | <0.001 |
| SBP (mmHg) | 0.200 | 0.001 | 0.001–0.004 | 3.024 | 0.003 |
| Dyslipidemia | 0.147 | 0.024 | 0.010–0.106 | 2.378 | 0.019 |
| DC (1/kPa) | |||||
| Constant | 0.037 | 0.003 | 0.031–0.043 | 12.140 | <0.001 |
| Age (years) | –0.361 | 0.000 | –0.0004–0.0002 | –4.900 | <0.001 |
| Dyslipidemia | –0.213 | 0.002 | –0.009– −0.002 | –2.888 | 0.004 |
| CC (mm2/kPa) | |||||
| Constant | 1.924 | 0.212 | 1.505–2.342 | 9.078 | <0.001 |
| Age (years) | –0.333 | 0.002 | –0.013– −0.005 | –4.266 | <0.001 |
| SBP (mmHg) | –0.235 | 0.002 | –0.009– −0.002 | –3.009 | 0.003 |
| α index | |||||
| Constant | –1.398 | 1.054 | –3.481–0.685 | –1.326 | 0.187 |
| Age (years) | 0.398 | 0.018 | 0.058–0.129 | 5.190 | <0.001 |
| PP (mmHg) | 0.202 | 0.022 | 0.015–0.104 | 2.632 | 0.009 |
| β index | |||||
| Constant | –2.945 | 2.103 | –7.099–1.028 | –1.401 | 0.163 |
| Age (years) | 0.403 | 0.036 | 0.120–0.262 | 5.296 | <0.001 |
| PP (mmHg) | 0.207 | 0.045 | 0.033–0.210 | 2.714 | 0.007 |
| PWVβ (m/s) | |||||
| Constant | –1.883 | 1.175 | –4.204–0.438 | –1.602 | 0.111 |
| Age (years) | 0.421 | 0.011 | 0.047–0.091 | 6.222 | <0.001 |
| SBP (mmHg) | 0.346 | 0.011 | 0.033–0.075 | 5.123 | <0.001 |